Yesterday's announcement of the safe progression of the lead-in study using only the CD19 expressing oncolytic virus is also good news for Arovella (if the ALA-101 / onCARlytics in vivo trial is successful).
onCARlytics update
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.005(3.33%) |
Mkt cap ! $162.9M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.5¢ | 15.0¢ | $69.37K | 457.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 591582 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 152161 | 7 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| ALA (ASX) Chart |